Clinical trial
Effect of Cardiotoxic Anticancer Therapy on the Metabolism of [1-13C]Pyruvate in Cardiac Mitochondria
NCT03685175 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Cardiotoxic Anticancer Therapy on the Metabolism of [1-13C]Pyruvate in Cardiac Mitochondria
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 3, 2018
- Completion date
- February 28, 2025
- Enrollment
- 79 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.